Safety and immunogenicity of a mosquito saliva peptide-based vaccine: a randomised, placebo-controlled, double-blind, phase 1 trial
National Institute of Allergy and Infectious Diseases (NIAID)
Jessica E Manning; Fabiano Oliveira; Iliano V Coutinho-Abreu; Samantha Herbert; Claudio Meneses; Shaden Kamhawi; Holly Ann Baus; Alison Han; Lindsay Czajkowski; Luz Angela Rosas; Adriana Cervantes-Medina; Rani Athota; Susan Reed; Allyson Mateja; Sally Hunsberger; Emma James; Olga Pleguezuelos; Gregory Stoloff; Jesus G Valenzuela; Matthew J Memoli
Biostatistics Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.